top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Application of Bioinformatics in Cancers
Application of Bioinformatics in Cancers
Autore Brenner J. Chad
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (418 p.)
Soggetto non controllato cancer treatment
extreme learning
independent prognostic power
AID/APOBEC
HP
gene inactivation biomarkers
biomarker discovery
chemotherapy
artificial intelligence
epigenetics
comorbidity score
denoising autoencoders
protein
single-biomarkers
gene signature extraction
high-throughput analysis
concatenated deep feature
feature selection
differential gene expression analysis
colorectal cancer
ovarian cancer
multiple-biomarkers
gefitinib
cancer biomarkers
classification
cancer biomarker
mutation
hierarchical clustering analysis
HNSCC
cell-free DNA
network analysis
drug resistance
hTERT
variable selection
KRAS mutation
single-cell sequencing
network target
skin cutaneous melanoma
telomeres
Neoantigen Prediction
datasets
clinical/environmental factors
StAR
PD-L1
miRNA
circulating tumor DNA (ctDNA)
false discovery rate
predictive model
Computational Immunology
brain metastases
observed survival interval
next generation sequencing
brain
machine learning
cancer prognosis
copy number aberration
mutable motif
steroidogenic enzymes
tumor
mortality
tumor microenvironment
somatic mutation
transcriptional signatures
omics profiles
mitochondrial metabolism
Bufadienolide-like chemicals
cancer-related pathways
intratumor heterogeneity
estrogen
locoregionally advanced
RNA
feature extraction and interpretation
treatment de-escalation
activation induced deaminase
knockoffs
R package
copy number variation
gene loss biomarkers
cancer CRISPR
overall survival
histopathological imaging
self-organizing map
Network Analysis
oral cancer
biostatistics
firehose
Bioinformatics tool
alternative splicing
biomarkers
diseases genes
histopathological imaging features
imaging
TCGA
decision support systems
The Cancer Genome Atlas
molecular subtypes
molecular mechanism
omics
curative surgery
network pharmacology
methylation
bioinformatics
neurological disorders
precision medicine
cancer modeling
miRNAs
breast cancer detection
functional analysis
biomarker signature
anti-cancer
hormone sensitive cancers
deep learning
DNA sequence profile
pancreatic cancer
telomerase
Monte Carlo
mixture of normal distributions
survival analysis
tumor infiltrating lymphocytes
curation
pathophysiology
GEO DataSets
head and neck cancer
gene expression analysis
erlotinib
meta-analysis
traditional Chinese medicine
breast cancer
TCGA mining
breast cancer prognosis
microarray
DNA
interaction
health strengthening herb
cancer
genomic instability
ISBN 3-03921-789-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367743403321
Brenner J. Chad  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Hereditary Hemorrhagic Telangiectasia : Recent Advances and Future Challenges
Hereditary Hemorrhagic Telangiectasia : Recent Advances and Future Challenges
Autore Mager Hans-Jurgen
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (228 p.)
Soggetto topico Research & information: general
Soggetto non controllato hereditary hemorrhagic telangiectasia
rare diseases
telangiectasis
transforming growth factor-beta (TGF-β)
Smad pathway
gastrointestinal bleeding
epistaxis
nosebleeds
tacrolimus
nasal ointment
genetic disease
rare disease
hereditary hemorrhagic telangiectasia (HHT)
telangiectases
mechanical damage
sun-induced trauma
vascular malformations
Endoglin
activin-receptor-like kinase 1
Hereditary Hemorrhagic Telangiectasia
antithrombotic therapy
anticoagulants
antiplatelets
bleeding
safety
HHT
ALK1
endoglin
raloxifene
bazedoxifene
tranexamic acid
propranolol
FK506
etamsylate
N-acetylcysteine
pulmonary arteriovenous malformations
transcatheter embolotherapy
screening
guidelines
Hereditary hemorrhagic telangiectasia
pediatrics
genotype–phenotype correlation
arteriovenous malformation
ENG
ACVRL1
SMAD4
microRNA
biomarker
plasma
arteriovenous malformations (AVMs)
angiogenesis
activin receptor-like kinase 1 (ALK1)
transforming growth factor beta (TGF-β)
bone morphogenetic protein (BMP)
propranolol gel
epistaxis severity score
nasal endoscopy
antiangiogenic properties
non-coding RNAs
microRNAs
long non-coding RNAs
biomarkers
endothelial cells
hereditary hemorrhagic telangiectasia (HHT), second-hit
arteriovenous malformation (AVM)
Smad4
inflammation
shear stress
vascular injury
somatic mutation
cell adhesion
vascular endothelial growth factor (VEGF)
telangiectasia
hereditary hemorrhagic
survival
life expectancy
pulmonary arteriovenous malformation
contrast enhanced magnetic resonance angiography
liver
MRI
ultrasound
AVM
bevacizumab
Osler–Weber–Rendu
hereditary hemorrhagic telangiectasia/HHT/osler’s disease
cerebral ischemic lesions
catheter based embolization therapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Hereditary Hemorrhagic Telangiectasia
Record Nr. UNINA-9910557578003321
Mager Hans-Jurgen  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer
Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer
Autore Nakayama Naomi
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (258 p.)
Soggetto topico Public health & preventive medicine
Soggetto non controllato nucleus accumbens-associated protein 1 (NAC1)
BEN (BANP, E5R and NAC1) domain
sequence-specific DNA-binding protein
solution NMR structure
isothermal titration calorimetry (ITC)
human cytomegalovirus
ovarian cancer
cancer progression
inflammation
immunosuppression
endometrial carcinoma
immune micro-environment
immune checkpoints inhibitors
microsatellite instability
mismatch repair deficiency
platelet-activating factor acetylhydrolase (PAF-AH
PLA2G7)
BRCA1 mutant ovarian cancer
Wnt signaling
pGSK3β
β-catenin
prognosis
vulvar melanoma
vaginal melanoma
targeted therapy
gynecological cancer
melanoma treatment
gene ontology
epithelial ovarian cancers
borderline ovarian tumors
differentially expressed genes
aryl hydrocarbon receptor
epithelial-mesenchymal transition
integrative analysis
testin
p16 protein
cervical cancer
cervical neoplasia
immunohistochemistry
chimeric antigen receptor
CD44
adoptive immunotherapy
NK cells
epithelial ovarian cancer
DNA damage response
somatic mutation
clear cell carcinoma
endometrioid endometrial cancer
DNA mismatch repair (MMR)
MMR deficient (dMMR)
long-term survival
exosome
miRNA
biomarkers
liquid biopsy
interventional radiotherapy
vaginal-cuff brachytherapy
HDR brachytherapy
in vivo dosimetry
endometrial cancer
biological planning
drug repurposing
non-coding RNAs
nanocarriers
anti-angiogenic therapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580209103321
Nakayama Naomi  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui